FDA Inspection 1167881 - Niagara Pharmaceuticals Inc - April 25, 2022

Record Details

This FDA Inspection record concerns Niagara Pharmaceuticals Inc, with an inspection on April 25, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Niagara Pharmaceuticals Inc
Inspection Date: April 25, 2022
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · ab045d3c-45f7-4c1d-86c2-6d21f4cb8a72

Violation Codes4

21 CFR 211.100(a)21 CFR 211.10321 CFR 211.22(d)21 CFR 211.84(b)

Full citation text and observation details available on the Dashboard.